Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (271)	3/24/2002 11:48:32 PM
From: Jibacoa	Read Replies (2) \| Respond to of 544

BLUD After its weak closing on Thursday, it reversed course with a buy signal and an up-gap at the opening of trading Friday.<g> siliconinvestor.com BLUD has been outperforming the general market since late December. siliconinvestor.com siliconinvestor.com Its up-trend seems to be now in high gear.<g> and it looks ready to test the February 2000 H at the 15.62 level, before it could try for the July 1999 H at 18.87 siliconinvestor.com BLUD develops, manufactures and sells a complete line of reagents and automated systems used primarily by hospitals, clinical laboratories and blood banks to detect and identify properties in the human blood. So far in the current fiscal year the net has been on black ink.<g> (Had $0.30 net in last Q and the estimated earnings for the current year is around $0.96) It expects to release its third quarter and year to date earnings on March 27, 2002, prior to the opening of regular trading hours, and then host a conference call on March 27, 2002 at 11:00 a.m. (EST) to review the results. They announced a deal with Bio-Rad last week for their European operations, which according with the company: "This relationship fits our strategy to become a dominant player in Europe through automation. Bio-Rad has a leading position in the French market and we believe the addition of Immucor's reagents and systems will support their efforts to significantly increase market share." Bernard